// App-Quantinova.ai

PB0455 : Low molecular weight heparin beyond 12 months in patients with cancer associated thrombosis. CAT-LONG study.

Researchers

Presenter

  • S. Lopez-Ruz

Principal Investigators

  • R. Otero-Candelera

  • L. Jara-Palomares

Medical Centers

  • Medical Surgical Unit of Respiratory Diseases. Hospital Universitario Virgen del Rocio, Sevilla, Spain, Sevilla, Andalucia, Spain

  • Medical Surgical Unit of Respiratory Diseases. Hospital Universitario Virgen del Rocio, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IbiS), Sevilla, Spain. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Córdoba, Andalucia, Spain

  • Medical Surgical Unit of Respiratory Diseases. Hospital Universitario Virgen del Rocio, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IbiS), Sevilla, Spain. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Córdoba, Andalucia, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Vasodilation dysfunction

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved